AI MARKET SCANNING

Kura Oncology Inc

🏛️ NASDAQ 📁 Health Technology 🏭 Biotechnology
AVG HISTORICAL GAP -0.79%
MAX GAP RECORD -7.24%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $KURA
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 12, 2026 Earnings Release 2026-08-12 (AFTER CLOSE)
+6.69%
Mar 05, 2026 Earnings Release 2026-03-05 (BEFORE OPEN)
-7.24%
Nov 04, 2025 Earnings Release 2025-11-04 (BEFORE OPEN)
-5.42%
Aug 07, 2025 Earnings Release 2025-08-07 (AFTER CLOSE)
-4.36%
Apr 30, 2025 Earnings Release 2025-04-30 (AFTER CLOSE)
-0.61%
Feb 26, 2025 Earnings Release 2025-02-26 (AFTER CLOSE)
+2.57%
Nov 07, 2024 Earnings Release 2024-11-07 (AFTER CLOSE)
-5.63%
Aug 08, 2024 Earnings Release 2024-08-08 (AFTER CLOSE)
+0.42%

VOLATILITY & GAP BIAS

AVG GAP MOVE 2.7%
Bullish Gaps (3)
Bearish Gaps (4)
Neutral / Flat (7)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $KURA

EXECUTIONS1 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
2026-10-28 🔒 PRO RADAR ••• x• $•••.•• → $•••.•• 1505m +15.43%
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib, which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia, KO-947, which is an ERK inhibitor for MAPK Pathway…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗